September 21, 2018
September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys…
September 21, 2018
September 21, 2018 — At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego,…
September 21, 2018
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking…
September 20, 2018
September 20, 2018 — At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego,…
September 20, 2018
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal…
September 20, 2018
September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT…
September 19, 2018
September 19, 2018 — DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound…
September 19, 2018
September 19, 2018 – The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE…
September 17, 2018
September 17, 2018 — Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a…
September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc. announced that its AltaValve transcatheter mitral valve replacement (…
September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare…
September 14, 2018
The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT)…
September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time…
September 13, 2018
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and…
September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore…
September 07, 2018
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival,…
September 07, 2018
September 7, 2018 — A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s…
September 06, 2018
September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart…
September 06, 2018
September 6, 2018 — While it is firmly established that the use of one internal thoracic artery can improve life…
September 06, 2018
September 6, 2018 – W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies…
